key: cord-0968731-qtmzwwm4 authors: Sultan, Laith R; Sehgal, Chandra M title: A review of early experience in lung ultrasound (LUS) in the diagnosis and management of COVID-19 date: 2020-05-25 journal: Ultrasound Med Biol DOI: 10.1016/j.ultrasmedbio.2020.05.012 sha: 35649ff6c6303b243e534d926be7de574b96dc1f doc_id: 968731 cord_uid: qtmzwwm4 Abstract A novel coronavirus (2019-nCoV) was identified as the cause of a cluster of pneumonia in Wuhan, China at the end of 2019. Since then more than four million confirmed cases of coronavirus disease 2019 (COVID-19) have been reported around the globe. The current gold standard for etiological diagnosis is reverse transcription polymerase chain reaction (rRT-PCR) analysis of respiratory tract specimens, but the test has a high false-negative rate due to both nasopharyngeal swab sampling error and viral burden. Hence diagnostic imaging has emerged as a fundamental component of current management of COVID-19 patients. Currently, high-resolution computed tomography (CT) is the main imaging tool for primary diagnosis and evaluation of disease severity in patients. Lung ultrasound (LUS) imaging has become a safe bedside imaging alternative that does no expose the patient to radiation, and minimizes the risk of contamination. Although the number of studies to date are limited, LUS findings have demonstrated high diagnostic sensitivity and accuracy, comparable to those of chest CT scans. In this article we review the current state of art of LUS in evaluating pulmonary changes induced by COVID-19. The goal is to identify characteristic sonographic findings most suited for the diagnosis of COVID-19 pneumonia infections. Coronavirus disease 2019 is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (WHO 2020). This disease was first identified in 2019 in Wuhan, China, and has since spread globally, resulting in the ongoing 2020 coronavirus pandemic (Hui et al. 2020; World Health Organization 2020) .The standard method of diagnosis is by reverse transcription polymerase chain reaction (rRT-PCR) from a nasopharyngeal swab (Releases 2020) , in addition to assessment of clinical symptoms, risk factors, and imaging features indicative of pneumonia (Practice 2020; Velavan and Meyer 2020) . Imaging features are determined largely by chest computed tomography (CT ) for diagnosis and during follow-up (Li et al. 2020a; Wang et al. 2020) . Although chest x-ray is typically the firstline imaging mode used on patients with suspected COVID-19, it has less sensitivity than chest CT scan (Wong et al. 2019 ). While chest CT has excellent ability to detect COVID-19 lung changes (Li et al. 2020b; , it has the disadvantages of large radiation exposure, lack of portability for bedside imaging, and risk of cross infections between patients. As a result, a significant interest has emerged in the use of lung ultrasound (LUS) as an alternative first-line imaging modality. LUS use has evolved over the years in the diagnosis of severe lung diseases in critically ill patients, complementing conventional assessment methods and other imaging modalities for lung (Arbelot et al. 2020; Bakhru and Schweickert 2013; Bouhemad B. et al. 2007; Lichtenstein and Malbrain 2017; Saraogi 2015) . LUS is cost effective, readily available at bedside, real-time, and free of radiation hazards. In the current COVID-19 pandemic, LUS is being used in emergency rooms for triaging symptomatic patients for pneumonia before hospital admission, monitoring patients with pneumonia related lung findings, managing ventilation and weaning for intensive care unit patients, and evaluating the effects of antiviral medications (Buonsenso et al. 2020b; Buonsenso et al. 2020a; Denina et al. 2020; Huang et al. 2020; Inchingolo et al. 2020; Kalafat et al. 2020; Lomoro et al. 2020; Musolino et al. 2020; Peng et al. 2020; Poggiali et al. 2020; Soldati et al. 2020 ; Thomas et al. 2020; Tung-Chen 2020; Yasukawa and Minami 2020) . This review article is aimed at the practitioners in various sub-specialties of allied health. It summarizes the current state of art of LUS and its emerging application for the diagnosis and management of COVID-19 patients. . The diagnostic findings of lung ultrasound imaging are based on the relative amounts of air and fluid present in the lung as determined by acoustic impedance (Z), a measure of the resistance of particles in a medium to mechanical vibrations (Miller 2016) . Z increases in proportion to the density of the tissue and to ultrasound velocity in the tissue. When ultrasound energy strikes a large, flat boundary between two media of different impedances, a part of the sound energy is reflected as an echo, and the remaining energy is transmitted across the boundary. The greater the difference in Z, the stronger the reflection and the weaker the transmission through the tissue. During LUS scanning the transducer is usually placed longitudinally, perpendicular to the ribs over intercostal space. The ultrasound beam propagates through skin, subcutaneous tissue, and muscles, to reach soft tissue-rib and visceral pleura-lung air boundaries. At the soft tissue-rib boundary the ultrasound wave is almost totally reflected back due to large acoustic impedance and the rib appears as a convex white (hyperechoic) bow-like line followed by posterior acoustic shadow beyond the boundary. Similarly, at the visceral pleura-lung air boundary, approximately 0.5 cm deeper and between upper and lower ribs in adults, almost all (> 99.9%) of the incident ultrasound is reflected back, leaving little to image beyond pleura (Aldrich 2007; Arbelot et al. 2020; Bouhemad B. et al. 2007 ). The result is that in a normally aerated lung, the only detectable structure is the pleura, visualized as a highly hyperechoic horizontal line (pleural line) ( Figure 1 ). This boundary appears as white band (lung/pleural line) measuring up to 2 mm (Koegelenberg et al. 2012) . Movement of visceral pleura over parietal pleura produces lung sliding, which makes the this white band appear dynamic. Lung sliding is the visualization of a regular rhythmic movement synchronized with respiration that occurs between the parietal and visceral pleura that are either in direct apposition or separated by a thin layer of intrapleural fluid. Lung sliding is an indicator of ventilation in the inspected area. Beyond this pleural line in normally aerated lung, artifacts are seen in the images (Lichtenstein et al. 2009 ). These are reverberation artifacts, produced by bouncing of echo between the pleural line and probe. In this context, the scattering of ultrasound waves produces artifacts on the images: horizontal reverberations of the pleural line (A-lines) (Figure 1 ). These artifacts usually appear as motionless, regularly spaced (equal to the distance between the skin and the pleural line) and gradually fading horizontal white lines which resemble pleural lines. The extent of these artifacts varies depending on the ratio of air and fluid in the lung. When the probe is positioned in the intercostal space, the pleural line and A-lines are visible in the images. When the probe is positioned longitudinally, the ribs cause posterior shadowing, but the pleural line and A-lines between the ribs are still clearly observable along with the shadowing. The characteristic appearance of two ribs with a pleural line in between is often referred to as the -bat sign‖ (Figure 1 ). While B-mode ultrasound is the major mode used for lung imaging, time motion mode (Mmode), the motion display of the ultrasound wave over time along a chosen ultrasound line, can provide extra diagnostic information. In M-mode, tissue structures up to the parietal pleura appear as horizontal lines, and the tissues beyond the pleura exhibit a sandy pattern characteristic of lung sliding, called the seashore sign ( Figure 2 ). The presence of pleural line, lung sliding, A-Lines in 2D, and seashore sign in M-mode indicate aerated lung (Lichtenstein et al. 2009; Lichtenstein and Mezière 2008) . Although there is a number of protocols for scanning the lungs described in the literature, one of the most commonly used is the Blue protocol (Lichtenstein and Mezière 2008; Miller 2016) because it is quick and simple, and provides a high diagnostic accuracy. As illustrated in Figure 3 , two hands are applied side by side (without thumbs) over the anterior chest with the wrists in When the ratio between air, tissue, fluid, or other biological components is reduced, the lung no longer presents as an almost complete specular reflector. Hence, various types of localized vertical artifacts appear in the ultrasound images due to the alterations of the subpleural tissue. These vertical artifacts of different shapes and lengths, often referred to as B-lines (Figure 4 ), occur when the lung loses normal aeration, but is not completely consolidated (Miller 2016; Saraogi 2015) . The reasons for these lines are not completely understood, but are multifactorial; possibly they represent acoustic channels of varying shapes and sizes generated by altered peripheral air-tissue space caused by pathological conditions. In essence, B-lines define discrete laser-like vertical hyperechoic reverberation artifacts that arise from the pleural line extending to the bottom of the screen without fading, moving synchronously with lung sliding. These B-lines are often visible in the images and are indications of abnormality, but they are not specific to a single pathology. However, clinical information accompanying imaging can help to distinguish different pathologies represented by B-lines. For example, the B-lines in a pregnant woman's lung sonogram, forming a pattern of vertical lines radiating into the lung tissue, indicated severe pulmonary edema, complicating previously undiagnosed pre-eclampsia (Zieleskiewicz et al. 2013 ). This presentation would not be associated with pulmonary fibrosis or chronic obstructive pulmonary disease, as they are typical pathologies of advanced age. Similarly, cardiogenic pulmonary edema is characterized by regular, laser-like, bright B-lines, particularly evident bilaterally on the lung bases (due to the gravitational effect on cardiogenic edema), without spared areas, and the pleural line is regular (Dietrich et al. 2016) . Conversely, in inflammatory lung disease such as viral pneumonia (including early stages of COVID-19), the pleural line is usually irregularly thickened (blurred), and with a characteristic distribution: monofocal or multifocal, patchy or inhomogeneous involvement, surrounded by spared areas and with no gravitational distribution. A few B-lines (<3/field of view) can often be found under normal circumstances, especially in the elderly, and around the base of the lungs. Another well-known phenomenon linked to increase in subpleural lung density, in the absence of consolidated tissue, is the coalescence of many vertical artifacts to form more extended echogenic patterns, either with recognizable individual artifacts, or with individual artifacts fused in a single homogeneous subpleural echogenic area (white lung) (Koegelenberg et al. 2012; Miller 2016) As the subpleural density approaches that of the solid tissue (~1 g/ml), consolidations appear in the image. When the density of the peripheral (subpleural) lung parenchyma increases, but not to the extent that it reaches consolidative state, as often happens in acute respiratory distress syndrome (ARDS) including COVID-19-induced ARDS, ultrasound examination shows a white area in which no horizontal reverberations (A-lines) nor separated Blines are visible ( Figure 5 ). This representation is commonly called as -ultrasonographic white lung.‖ On the other hand, when there is a complete consolidation of the lung, the echo structure of the lung itself becomes visible with characteristic air bronchogram, representing the air inside an alveoli or bronchi surrounded by inflammation or pus; and the pleural lines are completely obscured ( Figure 5 ). This section presents LUS findings from a number of COVID-19 cases reported from around the globe (Buonsenso et al. 2020b; Buonsenso et al. 2020a; Denina et al. 2020; Huang et al. 2020; Inchingolo et al. 2020; Kalafat et al. 2020; Lomoro et al. 2020; Musolino et al. 2020; Peng et al. 2020; Poggiali et al. 2020; Soldati et al. 2020; Thomas et al. 2020 ; Tung-Chen 2020; Yasukawa and Minami 2020). Our literature searches on PubMed and Google Scholar included using the following keywords: coronavirus, COVID-19, lung ultrasound, imaging findings for COVID-19. The search resulted in eleven case reports and studies published in the last two months for adult cases of COVID-9, including two from China, six from Italy, one from Japan, one from Canada, and one from Turkey. Each study contained a different number of cases, ranging from one case to 22 cases. Additionally, we include LUS findings reported by an emergency medicine physician in Spain who was infected with COVID-19 and recovered. We also looked at LUS findings reported in confirmed children with COVID-19 in two studies from Italy. The aim is to summarize the predominant LUS findings of COVID-19 pneumonia/ARDS, to define the patterns characteristic of COVID-19. Clinically, although a small percentage of cases (less than 10 percent) will show severe symptoms and complications from pneumonia-like changes in the lung, severe COVID-19 cases may rapidly progress to acute respiratory distress syndrome (ARDS), resulting in respiratory failure, septic shock, or multi-organ failure (Yang et al. 2020) . Therefore, it is important to assess the role of lung ultrasound as a tool for early detection of lung changes, as well as for monitoring patient prognosis longitudinally throughout the disease duration and recovery. Histopathological studies for patients with COVID-19 showed inflammatory pulmonary changes characterized by presence alveolar edema, reactive alveolar epithelial hyperplasia, prominent proteinaceous exudates, vascular congestion, and clusters with fibrinoid material, multinucleated giant cells, and, fibroblastic proliferation (fibroblast plugs). Reparative processes with pneumocyte hyperplasia and interstitial thickening can occur. The advanced phases show gravitational consolidations similar to those of the ARDS. At these phases we can see hemorrhagic necrosis, alveolar congestion, edema, flaking, and fibrosis. The accumulations of fluid in subpleural interstitial, alveolar spaces alter air-fluid ratio, producing B-lines which ranging from focal, to multifocal, to fused, according to the stage of the disease, until late stages where consolidation of the lung is observed. Table 1 summarizes typical lung ultrasonography findings reported from patients with COVID-19. A medical team from Xi'an Chest Hospital (Huang et al. 2020 ) reported LUS findings from 20 patients with confirmed COVID-19. Ultrasound exams were conducted using a 3-17 MHz highfrequency linear array transducer and 1-8 MHz convex array probe in six zones per lung within twelve lung scanning regions, an approach discussed below. The rationale for using the highfrequency linear array was its ability to clearly display the lung morphology and changes of subpleural lesions, as well as the changes of air and water contents in consolidated peripulmonary tissues. Furthermore, high-frequency imaging revealed air bronchogram signs in unconsolidated lung tissues caused by intra-pulmonary hemorrhage, which is of high significance in detecting the peri-pulmonary lesions. In the twelve-area examination, each lung was divided by anterior axillary and posterior axillary lines into three areas: anterior, lateral, and posterior. The two lobes of the lungs were divided into six areas each. The three dots used in the BLUE protocol discussed earlier (Lichtenstein and Mezière 2008; Miller 2016) pulmonary lobules were involved through interstitial inflammation, the interstitial tissues were thickened and swollen. Some bronchioles and alveoli were not involved because of high gas content and presented air bronchogram sign, visible in severe cases or local consolidation, possibly because local inflammation storm caused the consolidation and edema of most bronchioles and alveoli, and only large bronchi and part of the alveoli were not involved, as shown in Figure 9 , as diffuse B-lines. Color Doppler flow imaging (CDFI) ultrasound showed lack of blood flow signals in subpleural consolidation (Figure 8 a and 10) . Use of different ultrasound scanners showed the blood flow signal to be weak, possibly due to the pathological changes unique to COVID-19 lesions. Signs of weak or lack of blood flow, if confirmed by future studies, could be important biomarkers for COVID-19. In general, pulmonary consolidation caused by common inflammation is expected to show abundant blood flow, indicating good prognosis (Terslev et al. 2003) . In contrast to the expectations of increased blood flow observed during common inflammation, weak blood flow is observed with COVID-19, which is known to progresses rapidly and may cause death. Whether lung tissues are unable to quickly establish microvessel exchange mechanisms has yet to be further studied, but the ability of color Doppler ultrasound to detect the blood supply in consolidations more effectively than other imaging methods could make it ideal an ideal imaging method for identifying potential markers to predict the prognosis in the early stage of the disease. Peng et. al. (Peng et al. 2020) reported lung ultrasound studies of pneumonia in 20 cases with confirmed COVID-19 Their findings are consistent with the findings of the earlier study (Huang et al. 2020) . Although the publication did not provide details of the scanning protocol and the imaging systems used, the LUS patterns were observed across a continuum from mild alveolar interstitial pattern, to severe bilateral interstitial pattern, to lung consolidation. Characteristic Findings from patients were reported from Europe as COVID-19 spread. A study from Italy (Lomoro et al. 2020) provided an overview of multi-modality lung imaging findings in patients with COVID-19 pneumonia. LUS was performed in twenty-two patients from total of fifty-eight. Their results showed early pulmonary manifestations represented by a patchy distribution of interstitial artifactual signs (single and/or confluent vertical artifacts, small white lung regions). With the progress of infection, these patterns extend to multiple areas of the lung surface. The further evolution of lung abnormality (inflammation) presents as a patchy appearance of small subpleural consolidation with associated areas of white lung. Italian male with documented COVID-19 infection. The patient was admitted to the emergency department with fever, cough, asthenia, headache, myalgia, and photophobia for one week. The patient denied any travel during the prior months, but reported a history of contact with several Chinese people (none with documented COVID-19 infection) and Italian people from the City of Bergamo, currently considered a high-risk area for COVID-19 infection. His on-air oxygen saturation was 90% and low-flow oxygen therapy was started. The patient was evaluated with a portable lung ultrasound performed with 3.5 MHz convex probe. The portable device was used to minimize the risk of contamination and subsequent nosocomial spread despite its lowerquality images, compared to more advanced ultrasound imaging systems. The thorax was scanned at bedside using the 12-lung-areas approach: anterior superior and inferior, lateral superior and inferior, posterior superior and inferior, bilaterally. Lung ultrasound examination clearly documented signs of interstitial-alveolar damage with bilateral, diffuse pleural line abnormalities, subpleural consolidations, white lung areas, and thick, irregular vertical artifacts (B-lines). Spared areas were present bilaterally, mixed with pathological areas. In addition, the team reported a control case, imaged with the same device using the same ultrasound settings, performed during the same ED shift on a 38-year-old woman with high-grade fever, diffuse muscle and joint pain and cough, coming from a high-burden coronavirus area in Northern Italy, who eventually tested negative for COVID-19. Lung ultrasound showed a normal pleural line There is a report from Europe of personal experience using easily accessible portable ultrasound, from an emergency medicine physician in Spain who was infected while treating patients with COVID-19. The investigator, a 35-year-old male reported the day-by-day evolution of the disease evaluated by lung ultrasound (Figure 11 ). LUS showed thickening in the pleural lines at the beginning, which progressed to the formation of basal B-lines in the next few days. Over time, subpleural consolidations started to appear and spread bilaterally on both posterior lower lobes of LUS. A group from Japan reported LUS findings from ten confirmed COVID-19 patients (Yasukawa and Minami 2020) . Consistent with findings described previously, the presence of characteristic finding of diffuse B-line pattern, thick irregular pleural lines, confluent B lines, and subpleural consolidation were reported. The findings of multiple B-lines correlated with the ground-glass areas on CT and in turn a high-degree interstitial syndrome. Small subpleural consolidations were observed in five patients only while large consolidations were only observed in one patient. Only one case has been reported from North America, from Canada (Thomas et al. 2020) . Lung ultrasound of a 64-year-old female healthcare worker with no travel history, on day 10 after symptom onset, showed pleural thickening, subpleural consolidation, and multifocal B-lines. The latest case was reported from Turkey (Kalafat et al. 2020 ): a 32-year-old pregnant woman in her 35 th week who tested positive for COVID-19. LUS findings were consistent with viral pneumonia, with diffuse, thick B-lines bilaterally, with predominantly basal posterior lung involvement. The anterior segment of the right upper lobe did not show marked involvement and A-lines were visible on ultrasound. Chest CT findings correlated closely with those from LUS. Two studies from Italy reported LUS findings in children diagnosed with COVID-19. Mussolino were found to be in concordance with chest x-ray in all cases except one who had a normal chest radiography. A comparison between LUS and chest CT scan on the same patients showed a strong correlation between the two imaging modes (Huang et al. 2020; Peng et al. 2020) . The sensitivity and accuracy of LUS features were comparable to those from CT scan. Table 2 summarizes the features observed in LUS and its corresponding findings on chest CT scan. CT scans showed patchy, or confluent, patterns, appearing ground glass-opacity or mixed-consolidative and ground-glass patterns. 10% of lesions had a -crazy paving‖ appearance. The diagnoses made from the two image modalities were highly consistent, but CT showed clearer and complete intrapulmonary and apical lesions. Similar to CT, ground-glass opacity, nodule shadow, consolidation shadow, and air bronchogram signs are observed in ultrasound images. However, CT was found to be inferior to ultrasound in showing the smaller peri-pulmonary lesions and pleural and peri-pulmonary effusion (Huang et al. 2020) . Furthermore, the real-time and dynamic nature of ultrasound imaging was found to be advantageous in distinguishing interstitial lesions and visualizing the distribution of blood flow and angiogenesis in inflammatory lesions. A recognized limitation of lung ultrasonography is that it cannot detect lesions that are deep within the lung, as aerated lung blocks transmission of ultrasound; i.e., the abnormality must extend to the pleural surface to be visible with on ultrasonography examination. Chest CT is required to detect pneumonia that does not extend to the pleural surface. Despite the early advent of disease and the image findings are still evolving, the early experience from LUS use in COVID-19 cases is promising. Nearly all the studies using LUS for imaging COVID-19 patients have reported that characteristic ultrasound findings can be used to help physicians detect and stage the disease, and track its progression. The common patterns observed by the studies include bilateral and posterobasal predominance; and multiple B-lines ranging from focal to diffuse, with spared areas representing thickened subpleural interlobular septa. An irregular, thickened pleural lines with scattered discontinuities is commonly seen in the images. Subpleural consolidations can be associated with a discrete, localized pleural effusion. Color Doppler imaging shows inflammatory lesions to be relatively avascular. Alveolar consolidation having a tissue-like appearance, with dynamic and static air bronchograms, are often associated with severe, progressive disease. Restored aeration and reappearance of bilateral A-lines during recovery have been reported. Collectively, identification of these characteristic patterns can improve the specificity of LUS for imaging COVID-19 lung changes. While the results to date are encouraging, future studies optimizing the use of LUS will be helpful. This could include the use of a standardized lexicon for ultrasound features for classification of COVID-19 LUS, similar to those described in other areas of sonography of breast, liver and thyroid cancers. Using such lexicon can add objectivity to LUS features in differentiating COVID-19 from other disease by presence or absence of characteristic ultrasound features. Adding new features involving blood flow characteristic by Doppler ultrasound and visoelastic properties by elastography (Zhang et al. 2011 ) could also enhance diagnosis. Further improvements in diagnostic performance of LUS for COVID-19 can be achieved by combining advanced image analysis of LUS features with computer-aided diagnosis by machine learning. Establishment of a large, representative imaging dataset with contributions from multiple facilities will be needed for training and testing computer models. When trained on enough data, machine learning models often increase confidence in diagnosis, especially in lowresource communities around the globe that lack experience in LUS. Thickened pleura B-lines (multifocal, discrete, or confluent) Ground glass shadowing Confluent B lines Pulmonary infiltrating shadowing Small consolidations Subpleural consolidation Both non-translobar and translobar consolidation Translobar consolidation Pleural effusion is rare Pleural effusion is rare. Multilobar distribution of abnormalities More than two lobes affected Early stage findings: Focal B-lines and pleural line thickening Early stage findings: negative or atypical findings Progressive and late stage: confluent B-lines, pleural line thickening then small consolidation which progress to lobar consolidation. Progressive and late stage findings: diffuse scatte glass shadow which progress to lung consolidatio Basic physics of ultrasound imaging Lung Ultrasound in Emergency and Critically Ill Patients: Number of Supervised Exams to Reach Basic Competence Physics, equipment, and image quality Clinical review: Bedside lung ultrasound in critical care practice Point-of-Care Lung Ultrasound findings in novel coronavirus disease-19 pnemoniae: a case report and potential applications during COVID-19 outbreak Clinical role of lung ultrasound for the diagnosis and monitoring of COVID -19 pneumonia in pregnant women Lung Ultrasound in Children With COVID-19 Lung B-line artefacts and their use A Preliminary Study on the Ultrasonic Manifestations of Peripulmonary Lesions of Non-Critical Novel Coronavirus Pneumonia (COVID-19) The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health -The latest 2019 novel coronavirus outbreak in Wuhan The Diagnosis of Pneumonia in a Pregnant Woman with COVID-19 Using Maternal Lung Ultrasound Lung ultrasound and computed tomographic findings in pregnant woman with COVID-19 Transthoracic ultrasonography for the respiratory physician CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19) CT imaging changes of corona virus disease 2019(COVID-19): a multi-center study in Southwest China Lung ultrasound in the critically ill (LUCI): A translational discipline Relevance of lung ultrasound in the diagnosis of acute respiratory failure the BLUE protocol A-lines and B-lines: Lung ultrasound as a bedside tool for predicting pulmonary artery occlusion pressure in the critically ill COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review Practical approach to lung ultrasound Lung Ultrasound in Children with COVID-19: Preliminary Findings Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic Can Lung US Help Critical Care Clinicians in the Early Diagnosis of Novel Coronavirus (COVID-19) Pneumonia? Coronavirus disease 2019 New coronavirus stable for hours on surfaces Lung ultrasound: Present and future Is there a role for lung ultrasound during the COVID-19 pandemic? Estimation of inflammation by Doppler ultrasound: Quantitative changes after intra-articular treatment in rheumatoid arthritis Lung ultrasound findings in a 64-year-old woman with COVID-19 The COVID-19 epidemic Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area Naming the coronavirus disease (COVID-19) and the virus that causes it. World Heal. Organ Frequency and Distribution of Chest Radiographic Findings in COVID-19 Positive Patients World Health Organization W. WHO Director-General's opening remarks at the media briefing on COVID-19 -11 Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Point-of-Care Lung Ultrasound Findings in Patients with Novel Coronavirus Disease (COVID-19) Pneumonia Noninvasive ultrasound image guided surface wave method for measuring the wave speed and estimating the elasticity of lungs: A feasibility study Lung ultrasoundguided management of acute breathlessness during pregnancy We would like to thank Mr. Theodore W. Cary MS for his substantial contribution in reading and editing the manuscript.